Glenmark launches SUTIB (Sunitinib) – priced 96% lower than the innovator brand. Reduces the risk of kidney cancer progression by 58%
Glenmark Pharmaceuticals, a research-led, global integrated...
Glenmark launches COVID-19 drug Favipiravir at Rs 103 per tablet
Glenmark Pharmaceuticals has launched antiviral drug...